- Home
- KYMR vs FRHC Comparison
KYMR vs FRHC Comparison
Compare KYMR & FRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYMR | FRHC |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.8B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | KYMR | FRHC |
|---|---|---|
| Price | $104.20 | $154.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 26 | 0 |
| Target Price | ★ $107.72 | N/A |
| AVG Volume (30 Days) | ★ 558.9K | 134.6K |
| Earning Date | 04-30-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.29 |
| EPS | N/A | ★ 2.51 |
| Revenue | $39,211,000.00 | ★ $2,191,291,000.00 |
| Revenue This Year | $10.61 | N/A |
| Revenue Next Year | $8.17 | N/A |
| P/E Ratio | ★ N/A | $60.86 |
| Revenue Growth | N/A | ★ 6.86 |
| 52 Week Low | $36.88 | $107.98 |
| 52 Week High | $130.05 | $194.01 |
Technical Indicators
Market Signals| Indicator | KYMR | FRHC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 52.02 |
| Support Level | N/A | $130.81 |
| Resistance Level | N/A | $163.85 |
| Average True Range (ATR) | 0.00 | 6.24 |
| MACD | 0.00 | -0.71 |
| Stochastic Oscillator | 0.00 | 47.15 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with reportable segments into the following four segments: Brokerage, Banking, Insurance, and Other. The majority of revenue is from the Banking segment. Banking segment consists of the operations of Freedom Bank KZ and Freedom Bank TJ. Geographically, operates in Kazakhstan, Armenia, Cyprus, the USA, and others, with maximum revenue from Kazakhstan.